EUVIMEDEUVIMED entdecken
Open Access

The directed evolution of NDM-1

Caitlyn A Thomas iD, Zishuo Cheng iD, Christopher R Bethel, Andrea M Hujer, Aidan M Sturgill, Kelechi Onuoha, Richard C Page iD, Robert A Bonomo iD, Michael W Crowder iD

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.00714-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Caitlyn A Thomas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Miami University , Oxford, Ohio, USA. Hauptthemen laut MEDLINE: beta-Lactamases, beta-Lactams. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIGMS NIH HHS, U.S. Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

β-Lactam antibiotics are among the most frequently prescribed therapeutic agents. A common mechanism of resistance toward β-lactam antibiotics is the production of β-lactamases. These enzymes are capable of hydrolyzing the β-lactam bond, rendering the drug inactive. Among the four described classes, the metallo- β-lactamases (MBLs, class B) employ one or two zinc ions in the active site for catalysis. One of the three most clinically relevant MBLs is New Delhi Metallo- β-Lactamase (NDM-1). The current study sought to investigate the in vitro protein evolution of NDM-1 β-lactamase using error-prone polymerase chain reaction. Evaluation revealed that variants were not found to confer higher levels of resistance toward meropenem based on amino acid substitutions. Thus, we postulate that increases in transcription or changes in zinc transport may be clinically more relevant to meropenem resistance than amino acid substitutions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-Lactamasesbeta-LactamsMeropenemZincCatalytic DomainAnti-Bacterial Agentsbeta-Lactamase Inhibitors

Stichwörter der Autor:innen

NDM-1antibiotic resistanceantimicrobial resistancebeta-lactamasesbeta-lactamsdrug resistance evolution

Substanzen

Meropenembeta-Lactamasesbeta-LactamsZincAnti-Bacterial Agentsbeta-Lactamase Inhibitors

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, Miami University , Oxford, Ohio, USA.
  • Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center , Cleveland, Ohio, USA.
  • Department of Medicine, Case Western Reserve University School of Medicine , Cleveland, Ohio, USA.
  • Department of Biochemistry, Case Western Reserve University School of Medicine , Cleveland, Ohio, USA.
  • Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine , Cleveland, Ohio, USA.
  • Department of Pharmacology, Case Western Reserve University School of Medicine , Cleveland, Ohio, USA.

ORCID-Profile: Caitlyn A Thomas, Zishuo Cheng, Richard C Page, Robert A Bonomo, Michael W Crowder

Förderung

  • BLRD VA
  • NIGMS NIH HHS
  • U.S. Department of Veterans Affairs
  • HHS | National Institutes of Health

Zitieren

APA

Thomas, C. A., Cheng, Z., Bethel, C. R., Hujer, A. M., Sturgill, A. M., Onuoha, K., Page, R. C., Bonomo, R. A., & Crowder, M. W. (2023). The directed evolution of NDM-1. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00714-23

Vancouver

Thomas CA, Cheng Z, Bethel CR, Hujer AM, Sturgill AM, Onuoha K, et al. The directed evolution of NDM-1. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00714-23

BibTeX
@article{Thomas2023,
  author = {Thomas, Caitlyn A and Cheng, Zishuo and Bethel, Christopher R and Hujer, Andrea M and Sturgill, Aidan M and Onuoha, Kelechi and Page, Richard C and Bonomo, Robert A and Crowder, Michael W},
  title = {The directed evolution of NDM-1},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.00714-23}
}
Kostenlos starten →